autoinjector

Conclusion Authentic needle and drug-containing devices were used in order to provide a realistic assessment of the potential for limitations of usability with the SCTE-AI device. Results of this usability validation study indicate the low potential for physical harm associated with use of the...

This autoinjector will be approved by the end of 2017 in the U.S. The double-blind, multicenter Subcutaneous Testosterone Efficacy and Safety in Adult Men Diagnosed with Hypogonadism (STEADY) trial of a novel, pre-filled auto injector enrolled 150 hypogonadal adult men with two baseline...